4
Changes in Ownership
Cellectar Biosciences, Inc. Filed Acc 0001144204-18-062709
Director sold 992 shares at an average $2.21 ($2,192)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| HILL STEPHEN A Director | 2018-11-29 | Sale | −939 | $2.21 | $2,075 | 53 | D |
| HILL STEPHEN A Director | 2018-11-29 | Sale | −53 | $2.21 | $117 | 0 | D |
| Derivatives | |||||||
| HILL STEPHEN A Director | 2018-11-29 | Sale · Series A Warrants | +9,390 | $0.10 | $917 | 0 | D |
| HILL STEPHEN A Director | 2018-11-29 | Sale · Warrants | +530 | $0.05 | $27 | 0 | D |
| Open-market sales · 992 sh · avg $2.21 · $2,192 | |||||||
Loading xslF345X03/tv508276_4.xml…